Vitality Watch

Dossier pubmed review 15-oct-2026
Narrative review or expert overview without new data

Urinary organic acid analysis in preventive health assessment and healthy-aging research: A state-of-the-art review of evidence and methodological limitations.

Key claim: While urinary organic acid and metabolomic profiles associate with adiposity, metabolic health, and aging phenotypes, current evidence does not demonstrate that test-guided preventive assessments improve healthy-aging outcomes.

Abstract

Urinary organic acid (UOA) testing has established diagnostic applications in inherited metabolic disorders, but its relevance to preventive health assessment and healthy-aging research requires critical evaluation. This state-of-the-art review examines adult human evidence while distinguishing clinical organic acid testing, commercial panels, and targeted or untargeted urinary metabolomics. Eight complementary PubMed searches, supplemented by targeted reference-list checking, yielded 3054 unique records for title and abstract screening. Data from 38 human-study reports, including population characteristics, analytical methods, metabolites, outcomes, confounder adjustment, evaluation procedures, and study limitations, were extracted and synthesized narratively. Analytical and normalization strategies, interpretative limitations, and multi-omics approaches were critically appraised, distinguishing biological associations and exploratory prediction from validated clinical utility. Across the reviewed studies, urinary metabolite profiles were associated with adiposity, metabolic syndrome, renal outcomes, microbial features, and aging-related phenotypes. Evidence ranged from small cross-sectional investigations to population cohorts and prospective analyses, with independent-cohort replication of selected associations and external evaluation of selected predication models. Prospective findings concerned specific populations and outcomes, whereas aging-related evidence included both positive and null findings. Renal handling, sampling conditions, normalization, and analytical heterogeneity complicated comparisons across studies. Multi-omics investigations supported biological interpretation and exploratory prediction, but the reviewed studies did not establish that UOA-guided assessment improves preventive or healthy-aging outcomes. UOA testing has established diagnostic value in inherited metabolic disorders, while emerging human evidence supports further investigation of its relevance to preventive health assessment and healthy-aging research. Translation into routine care requires assay-specific validation and evidence that test-guided assessment or intervention improves clinically meaningful outcomes.

Why this matters

[expert-opinion] This review distinguishes urinary metabolomic associations with aging phenotypes from demonstrated clinical utility: current evidence does not establish that test-guided preventive assessments improve healthy-aging outcomes. [expert-opinion] It does not supply independent consumer-product validation or establish that changing a urinary profile constitutes de-aging.

Source

Link

Briefing card

Urinary organic acid analysis in preventive health assessment and healthy-aging research: A state-of-the-art review of evidence and methodological limitations.
Stage: review · pubmed · 15-oct-2026

If you use urinary organic acid testing for preventive health, this review found no validated evidence that care guided by the results improves healthy-aging outcomes.

While urinary organic acid and metabolomic profiles associate with adiposity, metabolic health, and aging phenotypes, current evidence does not demonstrate that test-guided preventive assessments improve healthy-aging outcomes.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.metop.2026.100511

build build 880 · 2bcef25 · 2026-11-18